Loading interactive chart...
1DInterval:
Date Range
1 min
Advertisement
United Therapeutics Corporation (UTH.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Follow
At close: 08:03AM CEST
Mountain
Settings
- Business Wire
United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2024 International Conference
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C., April 16, 2024--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that recent research across its commercial and development portfolio will be presented at the American Thoracic Society (ATS) International Conference in San Diego on May 17-22, 2024. At ATS, United Therapeutics will host an educational industry theater on implementing treprostinil induction strategies in pulmonary hypertension, and the
- ETF Trends
Innovation in Healthcare: HTEC’s Q1 2024 Index Rebalance
This article examines the first index rebalance and reconstitution of 2024 for the ROBO Global Healthcare Technology and Innovation Index, which underlies the $63 million ROBO Global Healthcare Technology and Innovation ETF (HTEC). Index movements are due to scoring changes from a combination of sector trends, individual companies’ financial health, quantitative analysis, and the insights [...]
- GuruFocus.com
Insider Sell: Chairperson & CEO Martine Rothblatt Sells 30,000 Shares of United ...
Martine Rothblatt, Chairperson & Chief Executive Officer of United Therapeutics Corp (NASDAQ:UTHR), sold 30,000 shares of the company on April 4, 2024, according to a recent SEC filing.
Advertisement
Advertisement
Advertisement